亚洲日韩欧美综合-亚洲日韩欧美一区二区在线-亚洲日韩欧美视频-亚洲日韩精品欧美一区二区-国产欧美日韩综合

DZD9008 TAK788

 
 
單價 600.00 / 克對比
銷量 暫無
發貨 山東濟南市付款后3天內
庫存 1000克起訂1克
品牌 番訊生物
含量 99.0%
顏色 白色或類白色
過期 長期有效
更新 2024-05-28 18:37
 

濟南川成醫藥科技開發有限公司

企業會員第12年
資料未認證
保證金未繳納
詳細說明

 

 

塞爾帕替尼LOXO-292   CAS:2152628-33-4

莫博替尼TAK788 CAS : 1847461-43-1

琥珀酸莫博替尼TAK788 CAS :2389149-74-8

TAS6417 CAS :1661854-97-2

布格替尼 CAS: 1197953-54-0

AZD3759 CAS1626387-80-1

卡博替尼 CAS:849217-68-1

蘋果酸卡博替尼 CAS:1140909-48-3

BDTX-189 CAS2414572-47-5

舒沃替尼DZD9008   CAS:2370013-49-1

他立替尼AB-106 CAS:1505515-69-4

妥卡替尼CAS:937263-43-9

枸櫞酸托瑞米芬 CAS:89778-27-8

枸櫞酸馬羅匹坦 CAS:359875-09-5

恩氯米芬檸檬酸鹽 CAS:7599-79-3

恩氯米芬*** CAS:14158-65-7

宗爾替尼BI-1810631   CAS:2728667-27-2

BI-4142 CAS2682003-36-5

RAD-140   CAS1182367-47-0 

CAS:2079068-74-7   化合物 T9175;A51新品

CAS:2079069-01-3   化合物A86新品

CAS2866415-98-5   BMS-986165(Deucravacitinib)的二代

1-甲級-1H-苯并(D)咪唑-5-醇 CAS:50591-22-5

3--6-三氟甲基噠嗪 CAS:258506-68-2

 

舉報收藏 0評論 0
更多>本企業其它產品
LOXO292塞爾帕替尼 布格替尼 恩氯米芬檸檬酸鹽 恩氯米芬檸檬酸鹽 BI-4142 琥珀酸莫博替尼TAK788 宗爾替尼BI-1810631 他立替尼AB-106 枸櫞酸托瑞米芬
 
主站蜘蛛池模板: | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |